ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 60 filers reported holding ESSA PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,221,421 | +14.4% | 1,042,531 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $2,814,834 | -9.1% | 1,042,531 | 0.0% | 0.01% | -14.3% |
| Q1 2023 | $3,096,317 | +17.9% | 1,042,531 | 0.0% | 0.01% | +16.7% |
| Q4 2022 | $2,627,178 | +38.5% | 1,042,531 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $1,897,000 | -42.2% | 1,042,531 | 0.0% | 0.01% | -37.5% |
| Q2 2022 | $3,284,000 | -65.6% | 1,042,531 | -32.4% | 0.01% | -55.6% |
| Q1 2022 | $9,533,000 | -56.5% | 1,542,531 | 0.0% | 0.02% | -53.8% |
| Q4 2021 | $21,904,000 | +77.5% | 1,542,531 | 0.0% | 0.04% | +62.5% |
| Q3 2021 | $12,340,000 | -68.0% | 1,542,531 | +14.3% | 0.02% | -68.4% |
| Q2 2021 | $38,570,000 | -1.7% | 1,350,000 | 0.0% | 0.08% | -5.0% |
| Q1 2021 | $39,218,000 | – | 1,350,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 8,748,629 | $15,923,000 | 0.66% |
| Soleus Capital Management, L.P. | 2,640,539 | $4,806,000 | 0.65% |
| Omega Fund Management, LLC | 328,196 | $597,000 | 0.22% |
| MPM BioImpact LLC | 405,700 | $738,000 | 0.18% |
| Bellevue Group AG | 5,898,583 | $10,736,000 | 0.15% |
| Rhenman & Partners Asset Management AB | 375,000 | $1,350,000 | 0.14% |
| PFM Health Sciences, LP | 1,478,252 | $2,690,000 | 0.10% |
| Frazier Life Sciences Management, L.P. | 692,910 | $1,261,000 | 0.10% |
| Avidity Partners Management LP | 2,460,000 | $4,477,000 | 0.09% |
| Eventide Asset Management | 1,561,251 | $2,841,000 | 0.06% |